Regulatory News
Monday, November 21, 2016
BRIEF-Sanofi says receives FDA approval of Soliqua 100/33
* Sanofi receives FDA approval of Soliqua(tm) 100/33, for
the treatment of adults with type 2 diabetes
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment